This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116%

Quantedge Capital added 212,600 shares of 10x Genomics in the first quarter, an estimated $4.25 million transaction based on quarterly average pricing. The filing reflects incremental institutional buying in a healthcare/biotech name rather than a company-specific operational update. The news is factual and likely has limited standalone market impact.

Analysis

Quantedge Capital added 212,600 shares of 10x Genomics in the first quarter, an estimated $4.25 million transaction based on quarterly average pricing. The filing reflects incremental institutional buying in a healthcare/biotech name rather than a company-specific operational update. The news is factual and likely has limited standalone market impact.